VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,106,000 | -50.3% | 117,647 | 0.0% | 0.04% | -45.0% |
| Q3 2018 | $2,226,000 | -3.2% | 117,647 | 0.0% | 0.08% | -1.2% |
| Q2 2018 | $2,299,000 | +4.0% | 117,647 | 0.0% | 0.08% | +5.2% |
| Q1 2018 | $2,211,000 | +13.2% | 117,647 | 0.0% | 0.08% | 0.0% |
| Q4 2017 | $1,953,000 | -19.4% | 117,647 | 0.0% | 0.08% | -29.4% |
| Q3 2017 | $2,422,000 | +129.8% | 117,647 | 0.0% | 0.11% | +94.6% |
| Q2 2017 | $1,054,000 | -32.3% | 117,647 | 0.0% | 0.06% | -6.7% |
| Q1 2017 | $1,558,000 | -48.0% | 117,647 | -50.0% | 0.06% | -51.2% |
| Q4 2016 | $2,998,000 | +6.1% | 235,294 | 0.0% | 0.12% | -6.1% |
| Q3 2016 | $2,826,000 | +9.3% | 235,294 | 0.0% | 0.13% | +28.4% |
| Q2 2016 | $2,586,000 | +25.9% | 235,294 | 0.0% | 0.10% | +17.2% |
| Q1 2016 | $2,054,000 | -60.1% | 235,294 | 0.0% | 0.09% | -58.4% |
| Q4 2015 | $5,153,000 | – | 235,294 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |